LncRNA495810 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells by Interacting with FABP5

被引:0
|
作者
Wu, Haili [1 ]
Yuan, Haiyan [2 ]
Duan, Yiwei [2 ]
Li, Guangjun [2 ]
Du, Jin'e [2 ]
Wang, Panfeng [3 ]
Li, Zhuoyu [2 ]
机构
[1] Shanxi Univ, Coll Life Sci, Taiyuan 030006, Peoples R China
[2] Shanxi Univ, Inst Biotechnol, Key Lab Chem Biol & Mol Engn, Minist Educ, Taiyuan 030006, Peoples R China
[3] Shanxi Prov Inst Stand Metrol Technol, Shanxi Prov Inspection & Testing Ctr, Taiyuan 030006, Peoples R China
来源
BIOLOGY-BASEL | 2024年 / 13卷 / 08期
基金
中国国家自然科学基金;
关键词
lncRNA495810; proliferation; migration; FABP5; hepatocellular carcinoma; ACID-BINDING PROTEIN; CANCER; INVASION;
D O I
10.3390/biology13080644
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary In this study, the expression, biological function and potential molecular mechanisms of a novel long non-coding RNA 495810 were detected in hepatocellular carcinoma cells. The results demonstrate a significant up-regulation of long non-coding RNA 495810 in hepatocellular carcinoma, and hepatocellular carcinoma patients with higher long non-coding RNA 495810 shows poorer overall survival and disease-free survival than those with lower long non-coding RNA 495810 level. Moreover, long non-coding RNA 495810 overexpression promotes the proliferation and migration, and blocks apoptosis and cell cycle arrest of hepatocellular carcinoma cells; while knock it down get the opposite results. Mechanistically, long non-coding RNA 495810 directly binds and up-regulates fatty acid binding protein 5 expression. In further, it was found that fatty acid binding protein 5 is up-regulated in hepatocellular carcinoma and associates with poor prognosis. More importantly, fatty acid binding protein 5 knockdown reverses the enhanced abilities of proliferation and metastasis induced by long non-coding RNA 495810 overexpression. These results reveal a novel mechanism of hepatocellular carcinoma metastasis guided by long non-coding RNA, providing a potential target for the treatment of liver cancer.Abstract Hepatocellular carcinoma (HCC) is one of the malignant tumors with high morbidity and mortality. Long non-coding RNAs (lncRNAs) are frequently dysregulated in human cancers and play an important role in the initiation and progression of HCC. Here, we investigated the expression of a new reported lncRNA495810 in our previous study by analyzing the publicly available datasets and using RT-qPCR assay. The cell proliferation experiment, cell cycle and apoptosis assay, wound healing assay, cell migration assay were used to explore the biological function of lncRNA495810 in HCC. The western blot, RNA pull down and RNA immunoprecipitation (RIP) detection were used to investigate the potential molecular mechanisms of lncRNA495810. The results demonstrated that lncRNA495810 was significantly upregulated in hepatocellular carcinoma and associated with poor prognosis of hepatocellular carcinoma patients. Moreover, it proved that lncRNA495810 promotes the proliferation and metastasis of hepatoma cells by directly binding and upregulating the expression of fatty acid-binding protein 5. These results reveal the oncogenic roles of lncRNA495810 in HCC and provide a potential therapeutic target for HCC.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p
    Yao, Jingjing
    Fu, Jindong
    Liu, Ying
    Qu, Wei
    Wang, Guangdong
    Yan, Zaojun
    ANNALS OF HEPATOLOGY, 2021, 23
  • [2] LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression
    Chen, Hang
    Li, Molin
    Huang, Ping
    JOURNAL OF CANCER, 2019, 10 (15): : 3571 - 3581
  • [3] Effect and Mechanism of LncRNA HOTAIR on Migration, Apoptosis and Proliferation of Hepatocellular Carcinoma Cells
    Quan, Gang
    Ren, Bo
    Xu, Jian
    Zhou, Jie
    Wu, Guo
    Li, Qiang
    Li, Jingdong
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2022, 12 (03) : 461 - 470
  • [4] LncRNA FABP5P3/miR-589-5p/ZMYND19 axis contributes to hepatocellular carcinoma cell proliferation, migration and invasion
    Zhu, Qian
    Luo, Zihua
    Lu, Guiyu
    Gui, Fenfang
    Wu, Jinghua
    Li, Faming
    Ni, Yong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 498 (03) : 551 - 558
  • [5] Up-regulation of Wnt5a inhibits proliferation and migration of hepatocellular carcinoma cells
    Wang, Tianxiao
    Liu, Xiaohong
    Wang, Jun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (04) : 904 - 908
  • [6] LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/-catenin signaling pathway
    Yu, Guangyu
    Wang, Wenshuang
    Deng, Junfeng
    Dong, Shaohua
    MOLECULAR MEDICINE REPORTS, 2019, 19 (05) : 3615 - 3621
  • [7] LncRNA AK001796 promotes cell proliferation via acting as a ceRNA of miR-150 in hepatocellular carcinoma
    Xu, Rui
    He, Haitao
    Wang, Yue
    Peng, Qi
    Mei, Ke
    Liu, Yan
    Yang, Qing
    GENETICS AND MOLECULAR BIOLOGY, 2023, 46 (02)
  • [8] lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4
    Zhang, Yixi
    Zhu, Zebin
    Huang, Shanzhou
    Zhao, Qiang
    Huang, Changjun
    Tang, Yunhua
    Sun, Chengjun
    Zhang, Zhiheng
    Wang, Linhe
    Chen, Huadi
    Chen, Maogen
    Ju, Weiqiang
    He, Xiaoshun
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [9] CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells
    Huang, Xiaoting
    Xiang, Leyang
    Wang, Baiyao
    Hu, Jijie
    Liu, Chunshan
    Ren, Anbang
    Du, Kunpeng
    Ye, Gengtai
    Liang, Yingying
    Tang, Yunqiang
    Yang, Dinghua
    Yuan, Yawei
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [10] ALKBH5 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by regulating TTI1 expression
    Chang, Qimeng
    Zhou, Xiang
    Mao, Huarong
    Feng, Jinfeng
    Wu, Xubo
    Zhang, Ziping
    Hu, Zhiqiu
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (05): : 1216 - 1230